* ContraFect Corp CFRX.OQ CFRX.O is expected to show no
change
in quarterly revenue when it reports results on May 12
(estimated).
* Refinitiv's mean analyst estimate for ContraFect Corp is
for a
loss of 31 cents per share. For the same quarter last year, the
company reported a loss of 18 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 5.2%
in the last three months.
* Wall Street's median 12-month price target for ContraFect
Corp
is $9, above its last closing price of $3.07.
* Previous quarterly performance (using preferred earnings
measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2021 -0.25 -0.27 -0.11 Beat 60
Sep. 30 2021 -0.29 -0.28 -0.13 Beat 54
Jun. 30 2021 -0.30 -0.28 -0.14 Beat 50
Mar. 31 2021 -0.22 -0.22 -0.18 Beat 18.2
Dec. -0.27 -0.31 -0.23 Beat 24.8
31 2020
Sep. 30 2020 -0.34 -0.38 0.12 Beat 131.4
Jun. 30 2020 -0.34 -0.37 -0.88 Missed -139.1
Mar. 31 2020 -0.64 -0.62 -0.49 Beat 21
This summary was machine generated May 10 at 17:19 GMT. All
figures in US dollars unless otherwise stated